テキサスにおける特発性肺線維症の臨床試験
テキサス内の拠点で、特発性肺線維症に関する11件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- El Paso Pulmonary Association, P.A., El Paso
- Baylor College of Medicine, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Houston
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/21更新 · NCT07652658A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Premier Pulmonary Critical Care and Sleep Medicine, PA, Denison
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/17更新 · NCT07516951RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Horizon Clinical Research Group, Cypress
- El Paso Pulmonary Association, PA, El Paso
- Elevate Clinical Research, Houston
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/14更新 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/03更新 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Baylor University Medical Center, Dallas
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/02更新 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- 他2件
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Dallas, TX, Dallas
被験者募集中第2相
40歳以上 · 全性別 · 2026/08/10更新 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。